Literature DB >> 3388021

Evidence of estrogen receptors in normal human osteoblast-like cells.

E F Eriksen1, D S Colvard, N J Berg, M L Graham, K G Mann, T C Spelsberg, B L Riggs.   

Abstract

In seven strains of cultured normal human osteoblast-like cells, a mean of 1615 molecules of tritium-labeled 17 beta-estradiol per cell nucleus could be bound to specific nuclear sites. The nuclear binding of the labeled steroid was temperature-dependent, steroid-specific, saturable, and cell type-specific. These are characteristics of biologically active estrogen receptors. Pretreatment with 10 nanomolar estradiol in vitro increased the specific nuclear binding of progesterone in four of six cell strains, indicating an induction of functional progesterone receptors. RNA blot analysis demonstrated the presence of messenger RNA for the human estrogen receptor. The data suggest that estrogen acts directly on human bone cells through a classical estrogen receptor-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3388021     DOI: 10.1126/science.3388021

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  199 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 3.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

4.  Response of biochemical markers of bone turnover to estrogen treatment in post-menopausal women: evidence against an early anabolic effect on bone formation.

Authors:  C E Fiore; P Pennisi; F G Tandurella; R Amato; L Giuliano; A Amico; G S Sciacchitano; S Caschetto
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

5.  Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.

Authors:  D Holmberg-Marttila; A Leino; H Sievänen
Journal:  Osteoporos Int       Date:  2003-02-12       Impact factor: 4.507

Review 6.  Postmenopausal hormone replacement therapy.

Authors:  H S Jacobs; F E Loeffler
Journal:  BMJ       Date:  1992-12-05

7.  Fetal antigen 2 (FA2) in human fetal osteoblasts, cultured osteoblasts and osteogenic osteosarcoma cells.

Authors:  D Tornehave; B Teisner; H B Rasmussen; J Chemnitz; M Kassem
Journal:  Anat Embryol (Berl)       Date:  1992-08

8.  Health and hormonal characteristics of premenopausal women with lower bone mass.

Authors:  M R Sowers; B Shapiro; M A Gilbraith; M Jannausch
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

Review 9.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

10.  Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro.

Authors:  M Kassem; W Blum; J Ristelli; L Mosekilde; E F Eriksen
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.